Pharmacogenomics guided antiplatelet selection strategy prior to intracranial or carotid stenting.

Not Applicable

Recruiting

• Conditions: carotid stenosis; Neurological - Other neurological disorders; aneurysm

• Registration Number: ACTRN12622000038796
• Lead Sponsor: Royal North Shore Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-01-17
• Last Update Posted: 24 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patient who are candidates for stenting.
Patients who are able to comply with dual antiplatelet therapy
Patients are willing to give informed written consent.
Patients aged 18 or older will be eligible.

Exclusion Criteria

Contraindications to antiplatelet treatment including but not limited to listed below
Acute or ongoing bleeding
Pregnancy
Thrombocytopenia ie. platelets < 50,000 per microL
Severe liver disease as determined by the treating physician
Renal Failure eGFR < 30 ml/min/1.73m2
Inability to comply with follow up visits.
Concurrent requirement for anticoagulation with warfarin or a NOAC
TPA use within the last 24 hours

Study & Design

• Study Type: Interventional
• Study Design: Not specified